Literature DB >> 15782117

The transcriptional factor YY1 upregulates the novel invasion suppressor HLJ1 expression and inhibits cancer cell invasion.

Chi-Chung Wang1, Meng-Feng Tsai, Tse-Ming Hong, Gee-Chen Chang, Chih-Yi Chen, Wen-Ming Yang, Jeremy J W Chen, Pan-Chyr Yang.   

Abstract

By using microarray and an invasion/metastasis lung cell line model, we identified the DnaJ-like heat shock protein 40, HLJ1, and found that the expression of HLJ1 correlates negatively with cancer cell invasion ability. Overexpression of HLJ1 can suppress cancer cell invasion in vitro. We further characterize the putative promoter region and investigate the transcriptional regulations of human HLJ1. A serial deletion of the 1.2 kb at the 5'-flanking region of the human HLJ1 gene was subcloned into a vector containing reporter gene and transfected into human lung adenocarcinoma cell line CL1-0, followed by luciferase activity assay. The results indicated that the region from -232 to +176 could drive the basal transcriptional activity of the HLJ1 gene. Sequence analysis of the HLJ1 gene promoter region showed absence of a TATA box, but identified an inverted CCAAT box and four YY1 transcriptional factor-binding sites, which may be important in the regulation of HLJ1 expression. Co-transfection of the YY1 and HLJ1 basal promoter regions, site-directed mutagenesis, and electrophoretic mobility shift assay confirmed that YY1 could upregulate HLJ1 basal promoter activity. Furthermore, we also demonstrated that overexpression of YY1 in CL1-0 cells can increase HLJ1 expression and reduce cell invasive capability. The reduction of cancer cell invasive ability is, at least in part, through upregulation of E-cadherin expression. The increase in HLJ1 and E-cadherin expression, as well as the suppression of invasion ability, can be reversed specifically by HLJ1 siRNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15782117     DOI: 10.1038/sj.onc.1208573

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  DNAJB6 induces degradation of beta-catenin and causes partial reversal of mesenchymal phenotype.

Authors:  Aparna Mitra; Mitchell E Menezes; Lalita A Shevde; Rajeev S Samant
Journal:  J Biol Chem       Date:  2010-06-03       Impact factor: 5.157

Review 2.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

Review 3.  The oncogenic role of Yin Yang 1.

Authors:  Qiang Zhang; Daniel B Stovall; Kazushi Inoue; Guangchao Sui
Journal:  Crit Rev Oncog       Date:  2011

4.  MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.

Authors:  Xiao Lu; Rui Liu; Meina Wang; Alagamuthu Karthick Kumar; Feiyan Pan; Lingfeng He; Zhigang Hu; Zhigang Guo
Journal:  Oncogene       Date:  2019-08-30       Impact factor: 9.867

5.  HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.

Authors:  Tolga Acun; Natalie Doberstein; Jens K Habermann; Timo Gemoll; Christoph Thorns; Emin Oztas; Thomas Ried
Journal:  OMICS       Date:  2017-05

6.  Secretomic analysis identifies alpha-1 antitrypsin (A1AT) as a required protein in cancer cell migration, invasion, and pericellular fibronectin assembly for facilitating lung colonization of lung adenocarcinoma cells.

Authors:  Ying-Hua Chang; Shu-Hui Lee; I-Chuang Liao; Shin-Huei Huang; Hung-Chi Cheng; Pao-Chi Liao
Journal:  Mol Cell Proteomics       Date:  2012-08-15       Impact factor: 5.911

Review 7.  Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancer.

Authors:  Meng-Feng Tsai; Chi-Chung Wang; Jeremy Jw Chen
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.

Authors:  Jason G Lieberthal; Marissa Kaminsky; Christopher N Parkhurst; Naoko Tanese
Journal:  Breast Cancer Res       Date:  2009-06-30       Impact factor: 6.466

9.  HLJ1 is a novel caspase-3 substrate and its expression enhances UV-induced apoptosis in non-small cell lung carcinoma.

Authors:  Sheng-Yi Lin; Chi-Mei Hsueh; Sung-Liang Yu; Chih-Chung Su; Weng-Yoon Shum; Kuan-Chuan Yeh; Gee-Chen Chang; Jeremy J W Chen
Journal:  Nucleic Acids Res       Date:  2010-05-21       Impact factor: 16.971

10.  HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.

Authors:  C-H Chen; W-H Chang; K-Y Su; W-H Ku; G-C Chang; Q-S Hong; Y-J Hsiao; H-C Chen; H-Y Chen; R Wu; P-C Yang; J J W Chen; S-L Yu
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.